Narrow Band Imaging in Diagnosis of Colorectal Polyps
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04831814 |
|
Recruitment Status :
Completed
First Posted : April 5, 2021
Last Update Posted : May 12, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Colorectal Polyp Colorectal Neoplasms | Diagnostic Test: Near Focus NBI Diagnostic Test: Standard Focus NBI | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 118 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Diagnostic |
| Official Title: | Near-focus Versus Normal-focus Narrow Band Imaging Colonoscopy in Diagnosis of Colorectal Polyps Based on Combined NICE and WASP Classification: a Randomized Controlled Trial |
| Actual Study Start Date : | April 4, 2019 |
| Actual Primary Completion Date : | July 2, 2020 |
| Actual Study Completion Date : | January 14, 2021 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Near Focus NBI
Use of the Near Focus NBI to make optical diagnosis
|
Diagnostic Test: Near Focus NBI
Colonoscopy with near focus narrowing band imaging technology . Optical specifications include a 2 mm near field focal depth. Optical diagnosis of polyps were according to NICE and WASP, respectively. |
|
Active Comparator: Standard Focus NBI
Use of the Standard Focus NBI to make optical diagnosis
|
Diagnostic Test: Standard Focus NBI
Colonoscopy with narrow band imaging technology.Optical diagnosis of polyps were according to NICE and WASP, respectively. |
- Rate of accurate polyp histology predictions by the Endoscopists in the two groups. [ Time Frame: At the time of procedure ]Measure of the percentage of accurate predictions by the endoscopists in the differentiation of neoplastic from non neoplastic colorectal lesions, using the high definition NBI colonoscopy with and without near focus features
- Rate of accurate diagnosis of sessile serrated polyps/adenoma by the Endoscopists in the two groups. [ Time Frame: At the time of procedure ]Measure of the percentage od accurate predictions by the endoscopists in the differentiation of sessile serrated polyps/adenoma from hyperplastic polyps, using the high definition NBI colonoscopy with and without near focus features.
- The polyp detection rate [ Time Frame: At the time of procedure ]The prevalence of patients with at least one polyp was detected
- The adenoma detection rate [ Time Frame: At the time of procedure ]The prevalence of patients with at least one adenoma was detected
- Diagnostic Characteristics [ Time Frame: At the time of procedure ]Compare the diagnostic characteristic (sensitivity, specificity, positive predictive value and negative predictive value) using the high definition narrow band imaging colonoscopy with and without near focus features.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 75 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients who were scheduled for colonoscopy at NKC institute
Exclusion Criteria:
- Inflammatory bowel disease
- Polyposis syndrome
- Colorectal cancer
- Active gastrointestinal bleeding
- Pregnant woman
- Inadequate bowel preparation
- Contraindication for polyps removal
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04831814
| Thailand | |
| Prince Songkla University | |
| Hat Yai, Songkhla, Thailand, 90110 | |
| Principal Investigator: | NISA NETINATSUNTON, MD. | NKC Institute of Gastroenterology and Hepatology, Prince of Songkla University |
| Responsible Party: | Nisa Netinatsunton, Principal Investigation, Prince of Songkla University |
| ClinicalTrials.gov Identifier: | NCT04831814 |
| Other Study ID Numbers: |
61355143 |
| First Posted: | April 5, 2021 Key Record Dates |
| Last Update Posted: | May 12, 2021 |
| Last Verified: | March 2021 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Colorectal Neoplasms Polyps Pathological Conditions, Anatomical Intestinal Neoplasms Gastrointestinal Neoplasms Digestive System Neoplasms Neoplasms by Site |
Neoplasms Digestive System Diseases Gastrointestinal Diseases Colonic Diseases Intestinal Diseases Rectal Diseases |

